An Approach to the Simultaneous Detection of Multiple Biomarkers for the Early Diagnosis of Liver Cancer Using Quantum Dot Nanoprobes
Authors:
- Jing FuJFJing Fu
- Zhi Editor(S): ChenZCZhi Editor(S): Chen
Open Access
- 2 February 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Infectious Microbes and Diseases
- Vol. 4 (1) , 34-40
Abstract
Biomarker-based early diagnosis of liver cancer is of high clinical value for reducing the mortality rate. However, it has been challenging to establish early detection methods with a single biomarker such as alpha-fetoprotein (AFP) because of limited diagnostic sensitivity and specificity. Therefore, developing multiplexed biomarker detection assays is crucially important for early diagnosis. Yet, simultaneous detection methods involving three or more biomarkers have been scarce. Here we suggest employing the serological biomarker panel of glypican-3 (GPC3), dickkopf-1 (DKK1), and AFP for liver cancer detection. We present a rapid simultaneous detection approach for the biomarker panel labeled with three fluorescent quantum dot nanoprobes (emission wavelengths at 565 nm, 605 nm, and 655 nm). As a proof-of-concept, simultaneous fluorescence detection of the biomarker panel was demonstrated using mixed reference samples containing human recombinant GPC3, DKK1, and AFP antigens. Our simultaneous detection approach conferred a linear range of 0.625-2.5 ng•mL-1 for the entire biomarker panel, which merits further clinical validation for the simultaneous and accurate determination of the biomarker panel in human serum samples.Keywords
This publication has 30 references indexed in Scilit:
- Simultaneous and combined detection of multiple tumor biomarkers for prostate cancer in human serum by suspension array technologyBiosensors and Bioelectronics, 2013
- Reevaluation of glypican-3 as a serological marker for hepatocellular carcinomaClinica Chimica Acta, 2013
- Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre studyThe Lancet Oncology, 2012
- Cross-talk-free simultaneous fluoroimmunoassay of two biomarkers based on dual-color quantum dotsAnalytica Chimica Acta, 2011
- Simultaneous detection of two lung cancer biomarkers using dual-color fluorescence quantum dotsThe Analyst, 2011
- Hepatitis B‐related hepatocellular carcinoma: epidemiological characteristics and disease burdenJournal of Viral Hepatitis, 2009
- Upregulation ofGlypican‐3expression in hepatocellular carcinoma but downregulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancersLiver International, 2005
- Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular CarcinomaCancer Research, 2004
- Semiconductor Nanocrystals as Fluorescent Biological LabelsScience, 1998
- Quantum Dot Bioconjugates for Ultrasensitive Nonisotopic DetectionScience, 1998